PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Compugen Ltd. (CGEN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINIL0010852080
CUSIPM25722105
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$230.99M
EPS-$0.21
Revenue (TTM)$33.46M
Gross Profit (TTM)$6.53M
EBITDA (TTM)-$12.52M
Year Range$0.53 - $3.03
Target Price$5.33
Short %2.17%
Short Ratio2.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Compugen Ltd.

Popular comparisons: CGEN vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Compugen Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%100.00%200.00%300.00%NovemberDecember2024FebruaryMarchApril
163.58%
17.59%
CGEN (Compugen Ltd.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Compugen Ltd. had a return of -4.04% year-to-date (YTD) and 206.45% in the last 12 months. Over the past 10 years, Compugen Ltd. had an annualized return of -15.22%, while the S&P 500 had an annualized return of 10.22%, indicating that Compugen Ltd. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-4.04%4.14%
1 month-29.37%-4.93%
6 months163.52%17.59%
1 year206.45%20.28%
5 years (annualized)-10.94%11.33%
10 years (annualized)-15.22%10.22%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202421.72%7.05%-0.00%
2023-18.42%-18.28%-12.80%198.78%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of CGEN is 91, placing it in the top 9% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of CGEN is 9191
Compugen Ltd.(CGEN)
The Sharpe Ratio Rank of CGEN is 8282Sharpe Ratio Rank
The Sortino Ratio Rank of CGEN is 9898Sortino Ratio Rank
The Omega Ratio Rank of CGEN is 9595Omega Ratio Rank
The Calmar Ratio Rank of CGEN is 9393Calmar Ratio Rank
The Martin Ratio Rank of CGEN is 8989Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Compugen Ltd. (CGEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CGEN
Sharpe ratio
The chart of Sharpe ratio for CGEN, currently valued at 1.04, compared to the broader market-2.00-1.000.001.002.003.001.04
Sortino ratio
The chart of Sortino ratio for CGEN, currently valued at 4.41, compared to the broader market-4.00-2.000.002.004.004.41
Omega ratio
The chart of Omega ratio for CGEN, currently valued at 1.49, compared to the broader market0.501.001.501.49
Calmar ratio
The chart of Calmar ratio for CGEN, currently valued at 2.03, compared to the broader market0.001.002.003.004.005.002.03
Martin ratio
The chart of Martin ratio for CGEN, currently valued at 7.56, compared to the broader market0.0010.0020.0030.007.56
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.66, compared to the broader market-2.00-1.000.001.002.003.001.66
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.44, compared to the broader market-4.00-2.000.002.004.002.44
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.29, compared to the broader market0.501.001.501.29
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.27, compared to the broader market0.001.002.003.004.005.001.27
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.65, compared to the broader market0.0010.0020.0030.006.65

Sharpe Ratio

The current Compugen Ltd. Sharpe ratio is 1.04. A Sharpe ratio greater than 1.0 is considered acceptable.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
1.04
1.66
CGEN (Compugen Ltd.)
Benchmark (^GSPC)

Dividends

Dividend History


Compugen Ltd. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-90.23%
-5.46%
CGEN (Compugen Ltd.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Compugen Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Compugen Ltd. was 97.90%, occurring on Nov 24, 2008. Recovery took 2953 trading sessions.

The current Compugen Ltd. drawdown is 90.23%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.9%Sep 6, 20002066Nov 24, 20082953Aug 19, 20205019
-97.28%Aug 26, 2020810Nov 13, 2023
-15.03%Aug 15, 20004Aug 18, 20002Aug 22, 20006
-2.06%Aug 20, 20201Aug 20, 20203Aug 25, 20204
-1%Aug 24, 20001Aug 24, 20001Aug 25, 20002

Volatility

Volatility Chart

The current Compugen Ltd. volatility is 16.77%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%NovemberDecember2024FebruaryMarchApril
16.77%
3.15%
CGEN (Compugen Ltd.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Compugen Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items